Skip to main content
. 2020 Jul 9;12(7):739. doi: 10.3390/v12070739

Figure 5.

Figure 5

DWV prevalence of injected pupae. X-axis, individual pupae treated as follows: Injected with DWV-P1 at 0.5 and 48 h (Sup. 0.5 and 48 h, respectively) supernatant from mock-infected cells (control) or uninjected (see Materials and Methods, Section 2.5).